A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.
作者： E. SANTAGOSTINO , M. E. MANCUSO , A. ROCINO , G. MANCUSO , F. SCARAGGI
DOI: 10.1111/J.1538-7836.2006.01772.X
关键词:
摘要: … results of a large trial with rFVIIa administered in … hemophiliacs with inhibitors, so that this study has addressed a clinical problem typical of patients with this complication of hemophilia…
core.ac.uk
elsevier.com
sci-hub.se 参考文章(12)
D M Monroe rd, M Hoffman, H R Roberts, Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII Blood Coagulation & Fibrinolysis. ,vol. 9, ,(1998)
Cornelis van 't Veer, Neal J. Golden, Kenneth G. Mann, Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa Blood. ,vol. 95, pp. 1330- 1335 ,(2000) , 10.1182/BLOOD.V95.4.1330.004K28_1330_1335
Louis Aledort, Diana Beardsley, Herbert Cooper, George Davignon, Bruce Ewenstein, Gerald Gilchrist, Joan Gill, Bertil Glader, W. Keith Hoots, C. Thomas Kisker, Jeanne Lusher, Cathy Rosenfield, Amy Shapiro, Horace Smith, Edwin Taft, Nigel Key, Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors Thrombosis and Haemostasis. ,vol. 80, pp. 912- 918 ,(1998) , 10.1055/S-0037-1615388
N. O'Connell, J. Chen, M. Byrne, E. O'Shea, H. Smyth, O. P. Smith, Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover British Journal of Haematology. ,vol. 116, pp. 645- 648 ,(2002) , 10.1046/J.0007-1048.2001.03297.X
G. Kenet, A. Lubetsky, J. Luboshitz, U. Martinowitz, A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven). Journal of Thrombosis and Haemostasis. ,vol. 1, pp. 450- 455 ,(2003) , 10.1046/J.1538-7836.2003.00059.X
LM Aledort, None, Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. Journal of Thrombosis and Haemostasis. ,vol. 2, pp. 1700- 1708 ,(2004) , 10.1111/J.1538-7836.2004.00944.X
E. Santagostino, A. Gringeri, P. M. Mannucci, Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention British Journal of Haematology. ,vol. 104, pp. 22- 26 ,(1999) , 10.1046/J.1365-2141.1999.01128.X
Saulius Butenas, Kathleen E. Brummel, Richard F. Branda, Sara G. Paradis, Kenneth G. Mann, Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. ,vol. 99, pp. 923- 930 ,(2002) , 10.1182/BLOOD.V99.3.923
S. Butenas, K. E. Brummel, B. A. Bouchard, K. G. Mann, How factor VIIa works in hemophilia. Journal of Thrombosis and Haemostasis. ,vol. 1, pp. 1158- 1160 ,(2003) , 10.1046/J.1538-7836.2003.00181.X
R. Parameswaran, A. D. Shapiro, J. C. Gill, C. M. Kessler, , Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia. ,vol. 11, pp. 100- 106 ,(2005) , 10.1111/J.1365-2516.2005.01075.X